136 related articles for article (PubMed ID: 9329676)
1. Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?
Hachinski V; Munoz DG
Ann N Y Acad Sci; 1997 Sep; 826():1-6. PubMed ID: 9329676
[TBL] [Abstract][Full Text] [Related]
2. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.
Kalaria RN
Ann N Y Acad Sci; 1999; 893():113-25. PubMed ID: 10672233
[TBL] [Abstract][Full Text] [Related]
3. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.
de la Monte SM; Sohn YK; Etienne D; Kraft J; Wands JR
Ann N Y Acad Sci; 2000 Apr; 903():61-71. PubMed ID: 10818490
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders.
Van Nostrand WE; Davis-Salinas J; Saporito-Irwin SM
Ann N Y Acad Sci; 1996 Jan; 777():297-302. PubMed ID: 8624102
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease.
Kalaria RN
Ann N Y Acad Sci; 1997 Sep; 826():263-71. PubMed ID: 9329698
[TBL] [Abstract][Full Text] [Related]
6. Cerebral vessels in ageing and Alzheimer's disease.
Kalaria RN
Pharmacol Ther; 1996; 72(3):193-214. PubMed ID: 9364575
[TBL] [Abstract][Full Text] [Related]
7. Differential degeneration of the cerebral microvasculature in Alzheimer's disease.
Kalaria RN; Hedera P
Neuroreport; 1995 Feb; 6(3):477-80. PubMed ID: 7766847
[TBL] [Abstract][Full Text] [Related]
8. [Neuropathology of the cerebral vessels of centenarians].
Hauw JJ; Zekry D; Seilhean D; Forette B; Gallinari C; Laurent M; Moulias R; Piette F; Sachet A; Duyckaerts C
J Mal Vasc; 2002 Jul; 27 Spec No():S13-8. PubMed ID: 12587216
[TBL] [Abstract][Full Text] [Related]
9. Cerebral vascular changes during chronic hypertension: good guys and bad guys.
Heistad DD; Baumbach GL
J Hypertens Suppl; 1992 Dec; 10(7):S71-5. PubMed ID: 1291659
[TBL] [Abstract][Full Text] [Related]
10. Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease.
Lyros E; Bakogiannis C; Liu Y; Fassbender K
Curr Alzheimer Res; 2014 Jan; 11(1):18-26. PubMed ID: 24251393
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
Kamat PK; Kyles P; Kalani A; Tyagi N
Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
[TBL] [Abstract][Full Text] [Related]
13. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.
Wisniewski HM; Vorbrodt AW; Wegiel J
Ann N Y Acad Sci; 1997 Sep; 826():161-72. PubMed ID: 9329688
[TBL] [Abstract][Full Text] [Related]
14. Selected histochemical and immunocytochemical markers of biological activity of brain blood vessels.
Kałuza J
Folia Neuropathol; 1995; 33(4):195-200. PubMed ID: 8673426
[TBL] [Abstract][Full Text] [Related]
15. More support for vascular basis of Alzheimer's disease.
Becker-Barroso E
Lancet Neurol; 2005 Oct; 4(10):598-9. PubMed ID: 16208856
[No Abstract] [Full Text] [Related]
16. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.
Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P
Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrovascular aging].
Buée L
Therapie; 1999; 54(1):155-65. PubMed ID: 10216439
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cerebral vasculature in normal and ischemic brain.
Kulik T; Kusano Y; Aronhime S; Sandler AL; Winn HR
Neuropharmacology; 2008 Sep; 55(3):281-8. PubMed ID: 18541276
[TBL] [Abstract][Full Text] [Related]
19. Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
Di Marco LY; Farkas E; Martin C; Venneri A; Frangi AF
J Alzheimers Dis; 2015; 46(1):35-53. PubMed ID: 25720414
[TBL] [Abstract][Full Text] [Related]
20. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
